Cargando…
Efficacy of mesenchymal stromal cells and cellular products in improvement of symptoms for COVID‐19 and similar lung diseases
At the end of 2019, respiratory coronavirus diseases 2019 (COVID‐19) appeared and spread rapidly in the world. Besides several mutations, the outcome of this pandemic was the death up to 15% of hospitalized patients. Mesenchymal stromal cell therapy as a therapeutic strategy seemed successful in tre...
Autores principales: | Banimohamad‐Shotorbani, Behnaz, Farajpour, Hekmat, Sefat, Farshid, Khosroshahi, Shiva Ahdi, Shafaei, Hajar, Heidari keshel, Saeed |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8014656/ https://www.ncbi.nlm.nih.gov/pubmed/33629351 http://dx.doi.org/10.1002/bit.27729 |
Ejemplares similares
-
Application of mesenchymal stem cell sheet for regeneration of craniomaxillofacial bone defects
por: Banimohamad-Shotorbani, Behnaz, et al.
Publicado: (2023) -
Stem Cell Niche Microenvironment: Review
por: Abdul-Al, Mohamed, et al.
Publicado: (2021) -
A critical review of fibrous polyurethane-based vascular tissue engineering scaffolds
por: Fathi-Karkan, Sonia, et al.
Publicado: (2022) -
Bioprinted Membranes for Corneal Tissue Engineering: A Review
por: Orash Mahmoud Salehi, Amin, et al.
Publicado: (2022) -
Emerging roles of mesenchymal stem cell therapy in patients with critical limb ischemia
por: Shirbaghaee, Zeinab, et al.
Publicado: (2022)